CEO Adam Szaronos provides a technology update at the Eyecelerator Conference WHITE PLAINS, N.Y., May 06, 2025 (GLOBE NEWSWIRE) — Iantrek, Inc., a leader in bio-interventional ophthalmic surgery (BIOS), today […]
Iantrek News
What's next in microinterventional ophthalmic surgery
Iantrek Announces Positive 2-Year Results Demonstrating Efficacy and Safety of Its Bio-Interventional Technology for Uveoscleral Outflow Enhancement in Glaucoma Patients
News | March 18, 2025
White Plains, NY — March 18, 2025 — Iantrek Corporation, a venture-backed ophthalmic technology company advancing novel interventional treatments for glaucoma, has announced the publication of positive 2-year results from its […]
Dr. Nathan Radcliffe on Advancing Uveoscleral Outflow
News | March 3, 2025
At the American Glaucoma Society Annual Meeting, Dr. Nathan Radcliffe discusses a poster he co-authored with Dr. Robert Weinreb, highlighting real-world insights into bio-interventional ophthalmic surgery (BIOS) and the role […]
Iantrek Appoints Adam Szaronos as Chief Executive Officer
News | February 4, 2025
WHITE PLAINS, N.Y., Feb. 04, 2025 (GLOBE NEWSWIRE) — Iantrek, Inc., a medical technology company pioneering bio-interventional approaches for chronic eye diseases, today announced the appointment of Adam Szaronos, as […]
Charting a New Course in Ophthalmic Innovation
News | October 22, 2024
At the American Academy of Ophthalmology, Iantrek Founder Dr. Sean Ianchulev shares his vision for the future of interventional glaucoma. Hear how Iantrek is pioneering Bio-Interventional Ophthalmic Surgery (BIOS) and […]
Iantrek Announces 1-Year Clinical Results of Its Bio-Interventional Technology for Uveoscleral Outflow Enhancement in Open-Angle Glaucoma Patients
News | September 17, 2024
Iantrek Announces 1-Year Clinical Results of Its (globenewswire.com) WHITE PLAINS, N.Y., Sept. 17, 2024 (GLOBE NEWSWIRE) — Iantrek, Inc., a venture-backed medical technology company pioneering next-generation bio- and micro-interventional approaches […]
Iantrek Announces Publication of Results of its Bio-interventional Uveoscleral Outflow Technology in Patients with Open-Angle Glaucoma
News | September 17, 2024
Iantrek Announces Publication of Results of its (globenewswire.com) WHITE PLAINS, N.Y., Sept. 11, 2024 (GLOBE NEWSWIRE) — Iantrek, Inc., a venture-backed, medical technology company pioneering next-generation bio- and micro-interventional approaches […]
Highlights from Glaucoma 360: Unveiling Iantrek Technology
News | February 19, 2024
We’re thrilled to share insights from our recent participation in the esteemed glaucoma congress, Glaucoma 360. This annual event brings together industry leaders, clinicians, and stakeholders dedicated to advancing the […]
Ophthalmology Times: Novel Supraciliary MIGS for Enhanced Suprachoroidal Outflow at AAO 23
News | November 8, 2023
Tsontcho (Sean) Ianchulev, MD, MPH, and colleagues reported on a new micro-interventional technique to enhance suprachoroidal outflow in patients with glaucoma at the American Academy of Ophthalmology annual meeting in […]
Discover Iantrek’s Cutting-Edge Presentations at AAO Event!
News | October 12, 2023
Iantrek is excited to announce our participation in the upcoming AAO event. We’re bringing you two captivating presentations.
No more posts to load!
